Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Reineke

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Biological Chemistry|September 12, 2002
Processing of the human transferrin receptor at distinct positions within the stalk region by neutrophil elastase and cathepsin GMatthias Kaup, Katrin Dassler, Ulrich Reineke, et al.
Vaccine|October 26, 2002
Identification of T helper cell-recognized epitopes in the chitinase of the filarial nematode Onchocerca volvulusBirgit Drabner, Ulrich Reineke, Jens Schneider-Mergener, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
<sup>177</sup>Lu-3BP-227 for Neurotensin Receptor 1-Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical ResultsRichard P Baum, Aviral Singh, Christiane Schuchardt, et al.
Journal of Immunological Methods|July 24, 2002
Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequencesUlrich Reineke, Claudia Ivascu, Marén Schlief, et al.
Molecular Cancer Therapeutics|November 16, 2004
Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancerSamuel Janssen, Carsten M Jakobsen, D Marc Rosen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2016
Comparative Evaluation of the Biodistribution Profiles of a Series of Nonpeptidic Neurotensin Receptor-1 Antagonists Reveals a Promising Candidate for Theranostic ApplicationsJörg Schulz, Martin Rohracker, Marvin Stiebler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 23, 2004
The ectodomain shedding of CD30 is specifically regulated by peptide motifs in its cysteine-rich domains 2 and 5Hinrich P Hansen, Andreas Recke, Ulrich Reineke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2026
Preclinical Development of 3BP-3940, a Fibroblast Activation Protein-Targeted Cyclic Peptide-Based Radiotheranostic for Imaging and TherapyDirk Zboralski, Frank Osterkamp, Jan L von Hacht, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2003
Designing isoform-specific peptide disruptors of protein kinase A localizationLora L Burns-Hamuro, Yuliang Ma, Stefan Kammerer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2017
Proof of Therapeutic Efficacy of a <sup>177</sup>Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft ModelJörg Schulz, Martin Rohracker, Marvin Stiebler, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biological Chemistry|September 12, 2002
Processing of the human transferrin receptor at distinct positions within the stalk region by neutrophil elastase and cathepsin GMatthias Kaup, Katrin Dassler, Ulrich Reineke, et al.
Vaccine|October 26, 2002
Identification of T helper cell-recognized epitopes in the chitinase of the filarial nematode Onchocerca volvulusBirgit Drabner, Ulrich Reineke, Jens Schneider-Mergener, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
<sup>177</sup>Lu-3BP-227 for Neurotensin Receptor 1-Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical ResultsRichard P Baum, Aviral Singh, Christiane Schuchardt, et al.
Journal of Immunological Methods|July 24, 2002
Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequencesUlrich Reineke, Claudia Ivascu, Marén Schlief, et al.
Molecular Cancer Therapeutics|November 16, 2004
Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancerSamuel Janssen, Carsten M Jakobsen, D Marc Rosen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2016
Comparative Evaluation of the Biodistribution Profiles of a Series of Nonpeptidic Neurotensin Receptor-1 Antagonists Reveals a Promising Candidate for Theranostic ApplicationsJörg Schulz, Martin Rohracker, Marvin Stiebler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 23, 2004
The ectodomain shedding of CD30 is specifically regulated by peptide motifs in its cysteine-rich domains 2 and 5Hinrich P Hansen, Andreas Recke, Ulrich Reineke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2026
Preclinical Development of 3BP-3940, a Fibroblast Activation Protein-Targeted Cyclic Peptide-Based Radiotheranostic for Imaging and TherapyDirk Zboralski, Frank Osterkamp, Jan L von Hacht, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2003
Designing isoform-specific peptide disruptors of protein kinase A localizationLora L Burns-Hamuro, Yuliang Ma, Stefan Kammerer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2017
Proof of Therapeutic Efficacy of a <sup>177</sup>Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft ModelJörg Schulz, Martin Rohracker, Marvin Stiebler, et al.
Pageof 3